HCW Biologics Inc. (NASDAQ:HCWB) Short Interest Up 13.2% in April theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 22,000 shares, a drop of 8.3% from the February 29th total of 24,000 shares. Approximately 0.1% of the shares of the company are […]
HCW Biologics (NASDAQ:HCWB) Stock Price Down 3.3% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Investigator Sponsor of HCW Biologics' (HCWB) Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Decreases By 53.1% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 21,400 shares, a decrease of 14.4% from the August 15th total of 25,000 shares. Currently, 0.1% of the company’s stock are short sold. […]
HCW Biologics Inc. (NASDAQ:HCWB) CFO Acquires $10,500.00 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
On September 13, 2023, Rebecca Byam, the Chief Financial Officer (CFO) of HCW Biologics Inc (NASDAQ:HCWB), made a significant insider purchase of 5,000 shares of the company's stock.
On September 12, 2023, Rebecca Byam, the Chief Financial Officer (CFO) of HCW Biologics Inc (NASDAQ:HCWB), made a significant insider purchase of 10,000 shares of the company's stock.